[HTML][HTML] Melanoma management: from epidemiology to treatment and latest advances

J Lopes, CMP Rodrigues, MM Gaspar, CP Reis - Cancers, 2022 - mdpi.com
Simple Summary Melanoma is a major public health issue that claims the lives of thousands
of people every year. Furthermore, the outlook for the coming years is not encouraging with …

Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy

B Neill, AR Romero, OS Fenton - ACS Applied Bio Materials, 2023 - ACS Publications
Messenger RNA (mRNA) vaccines are promising platforms for cancer immunotherapy
because of their potential to encode for a variety of tumor antigens, high tolerability, and …

The role of teledermatology during the COVID-19 pandemic: a narrative review

A Ruggiero, F Martora, G Fabbrocini… - Clinical, Cosmetic …, 2022 - Taylor & Francis
Teledermatology represented one of the most important and useful tools during the COVID-
19 pandemic era. Indeed, due to the severe restriction, and to reduce the spread of the …

[HTML][HTML] Management of advanced invasive melanoma: new strategies

A Villani, M Scalvenzi, G Micali, F Lacarrubba… - Advances in …, 2023 - Springer
The incidence of cutaneous melanoma (CM) is increasing. CM is defined as melanoma in
situ when limited within the epidermis and invasive when atypical melanocytes …

[HTML][HTML] Bcl-2 family inhibitors sensitize human cancer models to therapy

E Valentini, M Di Martile, M Brignone, M Di Caprio… - Cell Death & …, 2023 - nature.com
BH3 mimetics, targeting the Bcl-2 family anti-apoptotic proteins, represent a promising
therapeutic opportunity in cancers. ABT-199, the first specific Bcl-2 inhibitor, was approved …

[HTML][HTML] The Impact of Clinical and Histopathological Factors on Disease Progression and Survival in Thick Cutaneous Melanomas

DA Țăpoi, D Derewicz, AA Gheorghișan-Gălățeanu… - Biomedicines, 2023 - mdpi.com
Thick cutaneous melanomas (Breslow depth> 4 mm) are locally advanced tumors, generally
associated with poor prognosis. Nevertheless, these tumors sometimes display …

[HTML][HTML] The use of oncept melanoma vaccine in veterinary patients: A review of the literature

MKA Pellin - Veterinary sciences, 2022 - mdpi.com
Simple Summary Oncept is a vaccine that is used to treat melanoma, a cancer of pigmented
cells that can spread throughout the body, in dogs and other veterinary species. Its use is …

CaCO3-assistant synthesis of pH/near-infrared light-responsive and injectable sodium alginate hydrogels for melanoma synergistic treatment

J Lu, W Wang, Z Xu, P Zhang, J Gu, Z Xu, J Xi… - Journal of Colloid and …, 2023 - Elsevier
Melanoma is an aggressive tumor located in skin with high rates of recurrence and
metastasis. Due to the limited traditional therapies, the development of novel strategies …

[HTML][HTML] Killing three birds with one stone: Tumor-membrane-decorated Prussian blue nanovaccines for synergistic management of skin tumors, radiation dermatitis …

H Cui, X Zhang, Z Zhang, M Zhang, T Zhang… - Composites Part B …, 2023 - Elsevier
Unhealed wounds following the resection of malignant skin tumors, featuring incomplete
tumor tissue resection, full-thickness cutaneous defects, wound infection and radiation …

Cutaneous reactions following COVID-19 vaccination: a review of the current literature

F Martora, T Battista, C Marasca, L Genco… - Clinical, Cosmetic …, 2022 - Taylor & Francis
The outbreak of coronavirus disease 2019 (COVID-19) represented a new worldwide
challenge, strongly impacting on the global economy, overall health and lifestyle. Since …